MRGPRX1 agonist 1

CAS No. 2377379-39-8

MRGPRX1 agonist 1 ( —— )

Catalog No. M26306 CAS No. 2377379-39-8

MRGPRX1 agonist 1 is a highly potent MRGPRX1 (Mas-related G-protein-coupled receptor X1)agonist(EC50 of 50 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 430 Get Quote
25MG 710 Get Quote
50MG 972 Get Quote
100MG 1332 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MRGPRX1 agonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    MRGPRX1 agonist 1 is a highly potent MRGPRX1 (Mas-related G-protein-coupled receptor X1)agonist(EC50 of 50 nM).
  • Description
    MRGPRX1 agonist 1 is a highly potent MRGPRX1 (Mas-related G-protein-coupled receptor X1)agonist(EC50 of 50 nM).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antibiotic; Apoptosis; Autophagy; Bacterial; PTEN-induced kinase 1 (PINK1)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2377379-39-8
  • Formula Weight
    435.5
  • Molecular Formula
    C23H21N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccccc1S(=O)(=O)Nc1ccc(C)cc1Oc1ccc2c(N)nccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kondapalli C, et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2012 May;2(5):120080.
molnova catalog
related products
  • Ganoderic acid M

    Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low.

  • Soporidine

    Soporidine is a strigolactone (SL) antagonist and inhibitor of germination in their biological assays.

  • MP265

    MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.